OrthoPediatrics Corp. (NASDAQ: KIDS) is one of 20 publicly-traded companies in the “Medical Devices & Implants” industry, but how does it compare to its rivals? We will compare OrthoPediatrics Corp. to similar businesses based on the strength of its analyst recommendations, earnings, risk, valuation, profitability, institutional ownership and dividends.
Valuation and Earnings
This table compares OrthoPediatrics Corp. and its rivals revenue, earnings per share (EPS) and valuation.
|Gross Revenue||NetIncome||Price/Earnings Ratio|
|OrthoPediatrics Corp. Competitors||$1.67 billion||$207.58 million||72.45|
OrthoPediatrics Corp.’s rivals have higher revenue and earnings than OrthoPediatrics Corp..
Insider and Institutional Ownership
43.0% of shares of all “Medical Devices & Implants” companies are owned by institutional investors. 9.6% of shares of all “Medical Devices & Implants” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
This table compares OrthoPediatrics Corp. and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|OrthoPediatrics Corp. Competitors||-101.83%||-92.49%||-30.32%|
This is a breakdown of recent recommendations for OrthoPediatrics Corp. and its rivals, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|OrthoPediatrics Corp. Competitors||109||723||1018||10||2.50|
OrthoPediatrics Corp. presently has a consensus target price of $23.67, indicating a potential upside of 19.83%. As a group, “Medical Devices & Implants” companies have a potential upside of 42.09%. Given OrthoPediatrics Corp.’s rivals higher probable upside, analysts clearly believe OrthoPediatrics Corp. has less favorable growth aspects than its rivals.
OrthoPediatrics Corp. Company Profile
OrthoPediatrics Corp. is a medical device company. The Company designs, develops and commercializes orthopedic implants and instruments to meet the specialized needs of pediatric surgeons and their patients. It operates through the OrthoPediatrics segment, which designs, develops and markets implants and devices for children with orthopedic problems. Its products include RESPONSE Spinal Deformity System, PediNail Intramedullary Nail System, PediLoc Plating Systems, ACL Reconstruction System, Locking Cannulated Blade (LCB) plate system, Locking Proximal Femur (LPF) plate system, PediFlex Flexible Nailing System, PediFrag, PediLoc Extension Osteotomy Plate (PLEO), PediLoc Femur Locking Plate System, PediLoc Tibia Locking Plate System, PediPlates system and Spica Table. It markets over 20 surgical systems that serve approximately three categories within pediatric orthopedic market, including trauma and deformity, complex spine and anterior cruciate ligament reconstruction procedures.
Receive News & Ratings for OrthoPediatrics Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics Corp. and related companies with MarketBeat.com's FREE daily email newsletter.